Atlas Trials

Phase 1 Study to Compare the Safety, Pharmacokinetic Profiles of CJ-30056 and Lipitor/Glucophage XR

Clinical trial NCT02185066 · COMPLETED

Trial details

NCT number
NCT02185066
Sponsor
HK inno.N Corporation
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteers
Start date
2014-07-01
Primary completion
2014-09-01
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.